Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8990136 | 0.86 | ALPI (0.54) | SLC7A5TAAR1SLC6A2HDAC8 | |
| SCHEMBL8990144 | 0.86 | ALPI (0.54) | SLC7A5TAAR1SLC6A2HDAC8 | |
| Hydrochloric Acid SCHEMBL3050574 | 0.85 | ALPI (0.53) | SLC7A5HDAC8 | |
| Trifluoroacetic Acid SCHEMBL3051051 | 0.81 | ALPI (0.49) | SLC7A5HDAC8 | |
| SCHEMBL27337471 | 0.79 | SLC7A5 (0.62) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| Tyrosine Methyl Ester SCHEMBL313051 | 0.79 | ESR1 (0.63) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Tyrosine Methyl Ester SCHEMBL314923 | 0.79 | ESR1 (0.63) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Tyrosine Methyl Ester SCHEMBL1255129 | 0.79 | ESR1 (0.63) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL27680265 | 0.79 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL4453960 | 0.79 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2HDAC8ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-6794490-B2 | PEPTIDES FOR USE IN PREVENTION OF INFECTIONS; BACTERICIDES; MICROBIOCIDES | CUBIST PHARMACEUTICALS, INC. | 2004-09-21 | — | — | US | disclosed |
| EP-1240182-A2 | DAPTOMYCIN ANALOGS AND THEIR USE AS ANTIBACTERIAL AGENTS | Cubist Pharmaceuticals, Inc. (US) | 2002-09-18 | — | — | EP | disclosed |
| US-20020058785-A1 | Novel lipopeptides as antibacterial agents | MERCK SHARP & DOHME CORP. | 2002-05-16 | — | — | US | disclosed |
| WO-2001044271-A2 | DAPTOMYCIN ANALOGS AND THEIR USE AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058785-A1 | Novel lipopeptides as antibacterial agents | CLPTM1, NGLY1, VIP | SLC7A5 3306/4885TAAR1 4451/4885SLC6A2 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.